2025-07-17T13:17:06-05:00 2024-12-31 593040705 RIVERO GORDIMER & COMPANY PA 201 N FRANKLIN ST SUITE 2200 TAMPA FL 33602 990 2024-01-01 843548575 ANGELS FOR CHANGE INC ANGE 8135017742 1211 TECH BLVD 124 TAMPA FL 33619 LAURA BRAY PRESIDENT 3522000021 2025-07-09 1 0 SAM A LAZZARA P01342929 8138757774 2024 2025-03-06 01:10:19Z LAURA BRAY 2408 FOUNTAIN GRASS DRIVE VALRICO FL 33606 690254 0 X WWW.ANGELSFORCHANGE.ORG X 2019 FL OUR PURPOSE IS TO ENSURE ACCESS TO LIFE-SAVING DRUGS. OUR MISSION IS TO END DRUG SHORTAGES THROUGH ADVOCACY, AWARENESS AND A RESILIENT SUPPLY CHAIN. 6 6 3 6 0 0 292775 498002 37600 43000 152 182 57216 68629 387743 609813 174080 2885 0 0 81803 158273 0 0 818 116812 163304 372695 324462 15048 285351 208970 497833 2055 5567 206915 492266 X OUR PURPOSE IS TO ENSURE ACCESS TO LIFE-SAVING DRUGS. OUR MISSION IS TO END DRUG SHORTAGES THROUGH ADVOCACY, AWARENESS AND A RESILIENT SUPPLY CHAIN. 0 0 274276 2885 43000 WE ADVOCATE ON BEHALF OF ANY PATIENT IN A LIFE-SAVING DRUG SHORTAGE, WHILE BUILDING RELATIONSHIPS WITH PATIENTS AND MEMBERS OF THE PHARMACEUTICAL SUPPLY CHAIN TO END ALL HEALTHCARE CRISES CREATED BY DRUG SHORTAGES. WE OPERATE THE NATION'S ONLY DRUG SHORTAGE CRISIS LINE THROUGH OUR GLOBAL SUPPLY SHARING NETWORK TO ENSURE PATIENT ACCESS DURING A MARKET DISRUPTION. SINCE OUR FOUNDING, OUR PATIENT ADVOCACY HAS LED TO PROVIDING ACCESS TO OVER 750,000 LIFE-SAVING SHORTAGE TREATMENTS FOR PATIENTS, PHYSICIANS, AND HOSPITALS IN NEED. IN 2024, WE FOCUSED OUR EFFORTS ON ADVOCACY, ENGAGING IN SEVERAL NATIONAL STRATEGIC PATIENT ADVOCACY RELATIONSHIPS. CONTINUED ON SCHEDULE O.IN 2024, WE FACED THE HIGHEST NUMBER OF ACTIVE DRUG SHORTAGES EVER RECORDED - WITH 323 ONGOING DISRUPTIONS AND 99% OF HOSPITAL PHARMACISTS REPORTING DAILY SHORTAGES. BUT THANKS TO BOLD ADVOCACY, MEANINGFUL PARTNERSHIPS, AND AN UNSHAKABLE COMMITMENT TO PATIENTS, WE TURNED GROWING AWARENESS INTO FOCUSED, LIFE-SAVING ACTION. IN 2024 WE:- ADVOCATED FOR THOUSANDS OF PATIENTS DURING LIFE-SAVING DRUG SHORTAGES--OUR CORE MISSION AND GREATEST RESPONSIBILITY.- ACHIEVED A 98% SUCCESS RATE IN SUPPORTING PATIENT ACCESS THROUGH OUR DRUG SHORTAGE HOTLINE (DSH) AND GLOBAL SUPPLY SHARING NETWORK (GSSN).- PROTECTED DEXTROSE 70 AND ENSURED 1000 PATIENTS HAD ACCESS FROM THE IV FLUID SHORTAGE WITH PROJECT PROTECT.- ENGAGED WITH THE WHITE HOUSE, CONGRESS, AND FEDERAL AGENCIES TO PUSH FORWARD SYSTEMIC,BIPARTISAN POLICY SOLUTIONS.- RAISED NATIONAL AWARENESS THROUGH MEDIA COVERAGE, SPEAKING ENGAGEMENTS, AND OUR ANNUAL SUMMITONE--THE ONLY NATIONAL CONFERENCE FOCUSED EXCLUSIVELY ON ENDING DRUG SHORTAGES.-EXPANDED OUR COALITION OF CHAMPIONS AND CHANGE MAKERS ACROSS THE SUPPLY CHAIN TO BUILD A MORE RELIABLE,RESILIENT SYSTEM THAT PUTS PATIENTS FIRST. 274276 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 6 0 1 3 1 0 0 0 0 0 0 0 0 0 0 0 0 X 6 6 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 FL X LAURA BRAY 3522000021 2408 FOUNTAIN GRASS DRIVE VALRICO FL 33594 MELANIE BONNANO DIRECTOR OF ADVOCACY 2.00 X X 0 0 0 STEPHANIE MARTIN DIRECTOR OF LEGAL 2.00 X X 0 0 0 DIANE MASIELLO DIRECTOR OF COMMUNICATIONS 2.00 X X 0 0 0 FLORIENCIA NORRIS SECRETARY 2.00 X X 0 0 0 AUSTIN SIMON DIRECTOR OF MARKETING 2.00 X X 0 0 0 ALISON WALTERS DIRECTOR OF OPERATIONS 2.00 X X 0 0 0 LAURA BRAY CHIEF CHANGE MAKER 50.00 X 41000 0 0 41000 0 0 0 0 0 0 0 107500 390502 498002 SUMMIT REVENUE 541900 43000 43000 43000 182 182 149070 107500 80441 68629 68629 609813 43000 0 68811 X 2885 2885 41000 41000 103440 74552 28888 13833 11066 2767 6720 6720 69712 68299 1413 9536 7702 1834 2163 1049 296 818 9180 8059 1121 15000 12000 3000 28393 27551 842 148 148 269 269 404 404 SUMMIT EXPENSE 19150 19150 VOLUNTEER RECOGNITION 962 68 894 0 MEMBERSHIPS AND SUBSCRI 500 500 1167 126 1041 324462 274276 49368 818 207715 408851 181 86580 3209 807 1074 2402 208970 497833 2055 5567 2055 5567 X 206915 492266 206915 492266 208970 497833 285351 0 X 0 0 0 X 41981 211420 315089 292775 498002 1359267 3000 37600 43000 83600 41981 211420 318089 330375 541002 1442867 26120 20000 10000 10000 66120 150100 248218 398318 26120 20000 160100 258218 464438 978429 3 24 152 182 361 3 24 152 182 361 41981 211423 318113 330527 541184 1443228 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3209 807 2402 2402 609813 0 609813 0 609813 324462 0 324462 0 324462 GALA 256570 107500 149070 80441 256570 107500 149070 80441 80441 68629 FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED AND APPROVED ANNUALLY BY THE BOARD OF DIRECTORS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD OF DIRECTORS ASSESSES CONFLICTS OF INTEREST ON AN ANNUAL BASIS. FORM 990, PART VI, SECTION C, LINE 19 FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G CONTRACT LABOR: PROGRAM SERVICE EXPENSES 68,299. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 68,299. PAYROLL PROCESSING: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 1,413. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,413.